| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 428 |
| 1 | METHOTREXATE SODIUM | 321 |
| 2 | CYCLOPHOSPHAMIDE | 303 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 303 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 303 |
| 5 | METHYLPREDNISOLONE | 284 |
| 6 | METHOTREXATE | 276 |
| 7 | DEXAMETHASONE | 266 |
| 8 | DEXAMETHASONE 1.5 MG | 266 |
| 9 | CYTARABINE | 263 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DAUNORUBICIN HYDROCHLORIDE | 130 | 0.0789 |
| 1 | BUPROPION HYDROBROMIDE | 15 | 0.0260 |
| 2 | PEGASPARGASE | 235 | 0.0190 |
| 3 | MERCAPTOPURINE | 250 | 0.0143 |
| 4 | CHLORAMBUCIL | 50 | 0.0127 |
| 5 | CEFUROXIME AXETIL | 43 | 0.0123 |
| 6 | MESNA INJECTION | 97 | 0.0116 |
| 7 | MESNA | 97 | 0.0114 |
| 8 | ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN | 3 | 0.0087 |
| 9 | CALCIUM FOLINATE | 39 | 0.0082 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 703 |
| 1 | Alkylating Drug [EPC] | 353 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 277 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 277 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 264 |
| 5 | Topoisomerase Inhibitor [EPC] | 261 |
| 6 | Leukocyte Growth Factor [EPC] | 239 |
| 7 | Asparagine-specific Enzyme [EPC] | 235 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 84 |
| 9 | Benzodiazepine [EPC] | 71 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Asparagine-specific Enzyme [EPC] | 235 | 0.0174 |
| 1 | Topoisomerase Inhibitor [EPC] | 261 | 0.0034 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 8 | 0.0020 |
| 3 | Leukocyte Growth Factor [EPC] | 239 | 0.0017 |
| 4 | Human Immunoglobulin G [EPC] | 35 | 0.0017 |
| 5 | Alkylating Drug [EPC] | 353 | 0.0014 |
| 6 | Provitamin D2 Compound [EPC] | 43 | 0.0014 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 22 | 0.0010 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 277 | 0.0010 |